About Us
Novartis UK is the UK affiliate of Swiss based Novartis AG - one of the largest and most widely respected pharmaceutical companies in the world. Headquartered in Basel, Novartis employs nearly 100,000 people worldwide and has a presence in over 140 countries.
Brainsway Ltd. is dedicated to the development and marketing of Deep TMS (Transcranial Magnetic Stimluation) systems, novel, noninvasive medical device for treatment of a wide range of neurological and psychopathological disorders.
Euthymics Bioscience, Inc. is a neuroscience-focused, clinical-stage biopharmaceutical company. We are a group of experienced drug developers with a track record of success in neuroscience product development. We are dedicated to providing better medicines to patients with depression, adult ADHD and other areas of unmet medical need related to neuroscience.
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world.
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases.
Cortex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs called AMPAKINE molecules targeted towards the treatment of human central nervous system diseases.
